Table 2.
OCT features of eyes with steroid induced CSC (group A) and those with idiopathic CSC (group B)
| Group A N = 20 eyes | Group B N = 30 eyes | P value | OR (95% CI) | P value | |
|---|---|---|---|---|---|
| CMT (µm ± SD) | 370.25 ± 156.39 | 484.63 ± 222.02 | 0.08 | – | – |
| NSD height (µm ± SD) | 153.1 ± 175.70 | 312.9 ± 223.06 | < 0.01* | – | – |
| Subretinal deposits | 4/20 (20%) | 12/30 (40%) | 0.22 | 0.38 (0.10–1.40) | 0.14 |
| RPE irregularities | 5/20 (25%) | 5/30 (16.67%) | 0.49 | 1.67 (0.41–6.73) | 0.47 |
| PED | 5/20 (25%) | 11/30 (36.67%) | 0.54 | 0.58 (0.16–2.02) | 0.39 |
| Double layer sign | 4/20 (20%) | 11/30 (36.67%) | 0.35 | 0.43 (0.11–1.62) | 1.24 |
| Outer retinal layer disruption | 0/20 (0%, 95% CI, 0–16.11%) | 2/30 (6.67%) | 0.51 | 0.28 (0.01–6.10) | 0.42 |
| Hyperreflective dots | 3/20 (15%) | 14/30 (46.67%) | 0.03* | 0.20 (0.05–0.84) | 0.03* |
| Intraretinal fluid | 0/20 (0%, 95% CI, 0–16.11%) | 2/30 (6.67%) | 0.51 | 0.28 (0.01–6.10) | 0.42 |
| SFCT (µm ± SD) | 359.4 ± 49.10 | 355.53 ± 50.42 | 0.65 | – | – |
| SLCVD (µm ± SD) | 162.8 ± 39.01 | 163.38 ± 49.26 | 0.78 | – | – |
| CVI | 82 ± 35% | 58 ± 3% | 0.10 | – | – |
OCT optical coherence tomography; CMT central macular thickness; NSD neurosensory detachment; RPE retinal pigment epithelium; PED pigment epithelial detachment; CT choroidal thickness; SLCVD subfoveal large choroidal vessel diameter; CVI choroidal vascularity index; OR odds ratio; CI confidence interval
* Statistically significant